Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May flag early atherosclerosis in metabolic syndrome; leaves open whether monitoring or weight loss alters progression.
Metabolic syndrome is an accelerated systemic atherosclerotic process terminating with obesity, hypertension, diabetes mellitus, peripheric artery disease, chronic renal disease, chronic obstructive pulmonary disease, cirrhosis, coronary heart disease, stroke, and eventually early aging and death. It shows itself with some reversible components including smoking, overweight, hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, impaired fasting glucose, impaired glucose tolerance, and white coat hypertension (WCH). The terminal consequences are probably due to the smoking and excess weight induced chronic inflammatory process on the endothelial system for a long period of time. WCH is a pioneer sign of the accelerated systemic atherosclerotic process that can be detected easily, and treated by preventing weight gain.
No takes yet. Share an insight, caveat, or question.
Mehmet Rami Helvacı (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: